Device for creating and maintaining infusion passages in tissue

• US 8,128,656 B2
• Filed: 09/27/2005
• Issued: 03/06/2012
• Est. Priority Date: 12/04/2003
• Status: Active Grant

• Current Assignee: Ethicon Incorporated (Johnson & Johnson)
• Original Assignee: Ethicon Incorporated (Johnson & Johnson)
• Inventors: Cichocki, Frank R.
• Primary Examiner(s): NGUYEN, TUAN VAN
• Application Number:
  US11/235,853
• Publication Number:
  US 20060030883A1
• Time in Patent Office: 2,352 Days
• Field of Search: 606/228, 606/108, 606/222, 128/898, 604272-274, 604541-543
• US Class Current: 606/228
• CPC Class Codes: A61B 17/06 Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials puncturing needles A61B17/34; hypodermic needles A61M5/32 ; sewing needles D05B85/00
• CPC Class Codes: A61B 17/06166 Sutures suture materials A61L17/00; manufacture of artificial threads D01D; treatment of threads D06M
• CPC Class Codes: A61B 2017/0458 Longitudinal through hole, e.g. suture blocked by a distal suture knot
• CPC Class Codes: A61B 2017/0461 with features cooperating with special features on the suture, e.g. protrusions on the suture
• CPC Class Codes: A61B 2017/0464 for soft tissue
• CPC Class Codes: A61B 2017/06185 hollow or tubular

Abstract

Methods and devices are disclosed for the in-vivo creation and maintenance of contiguous fluid passages in tissue through the use of tissue buttressing portions with interrupted perimeter walls. These portions can be formed from hollow fiber or extruded components. One end of the tissue-buttressing portion is connected to a hollow tube, which may be connected to a fluid source. The other end of the buttressing portion may be attached to a needle or other device suitable for the penetration of tissue and the formation of passageways in tissue. When the device is installed in tissue, the hollow tube portion of the device is passed part way through the surface of the patient and serves as the conduit for the transfer of fluid to the implanted tissue-buttressing portion of the device. The presence of the buttressing portion within the tissue causes a bridging of the local tissue thereby forming an infusion passage between the external surface of the buttressing portion and the abutting tissue. Therapeutic fluids may be passed from the hollow fiber conduit of the device and though the infusion passage created by the buttressing portion of the device and the surrounding tissue.

Claims

1. A method of introducing fluid to a tissue site in tissue in a patient, comprising the steps of:

1) piercing the tissue in or in proximity to the tissue site with a surgical needle that is attached to a first distal end portion of an elongate flexible tubular member, the elongate flexible tubular member comprising a second hollow tubular proximal end portion having a continuous side wall, the first distal end portion, and a tissue-buttressing portion having an external surface, located between the first and second end portions, wherein the tissue buttressing portion has a length and comprises a fiber bundle, wherein the fiber bundle has a plurality of solid fibers in fluid communication with the second proximal end portion to allow fluid to be emitted there from along the length at a location adjacent to the wound site;

     2) advancing the surgical needle and elongate flexible tubular member into tissue in or in proximity to the tissue site so that at least a portion of the tissue buttressing portion of the elongate flexible tubular member is in or in proximity to the tissue site and the proximal end portion is at least in part external of the tissue, and forming an infusion passage between the external surface of the tissue buttressing portion and abutting tissue;

     3) removing the surgical needle from the distal end portion; and

,

     4) supplying pressurized fluid to the infusion passage and the tissue site via the tubular proximal end portion and the tissue buttressing portion.

2. The method of claim 1, further comprising the step of securing the elongate flexible tubular member with one or more knots in or in proximity to the tissue site.

3. The method of claim 1, wherein the elongate flexible tubular member comprises one or more polymers selected from the group consisting of polyglycolic acid (PGA), polylactic acid (PLA), PGA/PLA copolymers, polycaprolactone (PCL), PCUPGA copolymers, polydioxanone, trimethylcarbonate (TMC), polyproylene, polyamide, polytetraflouroethylene (PTFE), and polyethylene.

4. The method of claim 3, wherein the elongate flexible tubular member comprises an absorbable polymer.

5. The method of claim 1, wherein the diameter of the elongate flexible tubular member has a diameter along each portion of from about 0.005″

to about 0.030″

.